Providing market intelligence for more than 35 years

In The News

Research: Sony’s Share Of Smart TV Purchases Grew In 2021

Parks Associates shares its latest Consumer Insights Dashboard, which tracks adoption, purchases, and demand across most common consumer electronics products

“Samsung continues to lead smart TV adoption, and it currently comprises over one-fourth of all consumers’ primary smart TVs in the U.S.,” says Paul Erickson, director, research, Parks Associates. “While smart TV adoption is at all-time highs, there may be short-term saturation and conservatism in effect while consumer smart TV purchasing settles following dramatic increases in 2020. Sony still managed to grow in purchasing — despite downturns for the traditional top three brands — which may be related to its first-mover release of new Google TV Bravia models over 2021.”

From the article "Research: Sony’s Share Of Smart TV Purchases Grew In 2021."

Previously In The News

AT&T kills Plenti loyalty program but touts ongoing Thanks campaign

Parks Associates reported last year that 60% of respondents in a survey valued a rewards program for being a loyal customers, third only to the ability to roll over unused data (66%) and free access t...

One in five US subscribers now ‘dissatisfied’ with pay TV service

Some 20% of US pay TV subscribers are now dissatisfied with their pay TV service, according to research from Parks Associates. The future represents a 100% increase since 2013, according to Parks....

With 1 Gbps speeds, Verizon’s 5G fixed wireless service will leapfrog the competition

And speeds appear to matter. Parks Associates reported way back in 2015 that fully one quarter of Americans who switched to a new ISP "did so in order to obtain a faster service at a comparable price....

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...